Table 1.
Demographic and Clinical Characteristics of the 105 HCC Patients
| Variables | Categories | n (%) |
|---|---|---|
| Age (years) | <45 vs. ≥45 | 43 (41) vs 62 (59) |
| Sex | Male vs. Female | 91 (86.7) vs 14 (13.3) |
| HBsAg | Negative vs. Positive | 12 (11.4) vs 93 (88.6) |
| HBV-DNA | <5.0×102 vs. ≥5.0×102 | 30 (28.6) vs 75 (71.4) |
| AFP (ng/mL) | <400 vs. ≥400 | 46 (43.8) vs 59 (56.2) |
| Tumor size (cm) | <5 vs. ≥5 | 23 (21.9) vs 82 (78.1) |
| Tumor number | Single vs. Multiple | 65 (61.9) vs 40 (38.1) |
| Liver cirrhosis | Negative vs. Positive | 4 (3.8) vs 101 (96.2) |
| Edmondson Grade | I–II vs. III–IV | 63 (60.0) vs 42 (40.0) |
| BCLC stage | 0-A vs. B-C | 57 (54.3) vs 48 (45.7) |
| Tumor Capsule | Complete vs. Incomplete | 64 (61.0) vs 41 (39.0) |
| MVI | Negative vs. Positive | 33 (31.4) vs 72 (68.6) |
| PVTT | Negative vs. Positive | 82 (78.1) vs 23 (21.9) |
Abbreviations: AFP, alpha-fetoprotein; BCLC stage, Barcelona Clinic Liver Cancer stage; HBsAg, hepatitis B surface antigen; HBV-DNA, hepatitis B virus DNA; HCC, hepatocellular carcinoma; MVI, microvascular invasion; PVTT, portal vein tumor thrombosis.